109 related articles for article (PubMed ID: 11212120)
1. FR131535, a novel water-soluble echinocandin-like lipopeptide: synthesis and biological properties.
Fujie A; Iwamoto T; Sato B; Muramatsu H; Kasahara C; Furuta T; Hori Y; Hino M; Hashimoto S
Bioorg Med Chem Lett; 2001 Feb; 11(3):399-402. PubMed ID: 11212120
[TBL] [Abstract][Full Text] [Related]
2. Chemical diversity in lipopeptide antifungal antibiotics.
Hino M; Fujie A; Iwamoto T; Hori Y; Hashimoto M; Tsurumi Y; Sakamoto K; Takase S; Hashimoto S
J Ind Microbiol Biotechnol; 2001 Sep; 27(3):157-62. PubMed ID: 11780786
[TBL] [Abstract][Full Text] [Related]
3. Novel echinocandin antifungals. Part 1: novel side-chain analogs of the natural product FR901379.
Tomishima M; Ohki H; Yamada A; Maki K; Ikeda F
Bioorg Med Chem Lett; 2008 Feb; 18(4):1474-7. PubMed ID: 18207736
[TBL] [Abstract][Full Text] [Related]
4. WF11899A, B and C, novel antifungal lipopeptides. II. Biological properties.
Iwamoto T; Fujie A; Nitta K; Hashimoto S; Okuhara M; Kohsaka M
J Antibiot (Tokyo); 1994 Oct; 47(10):1092-7. PubMed ID: 7961157
[TBL] [Abstract][Full Text] [Related]
5. Novel echinocandin antifungals. Part 2: Optimization of the side chain of the natural product FR901379. Discovery of micafungin.
Tomishima M; Ohki H; Yamada A; Maki K; Ikeda F
Bioorg Med Chem Lett; 2008 May; 18(9):2886-90. PubMed ID: 18424132
[TBL] [Abstract][Full Text] [Related]
6. Cilofungin inhibition of (1-3)-beta-glucan synthase: the lipophilic side chain is essential for inhibition of enzyme activity.
Taft CS; Selitrennikoff CP
J Antibiot (Tokyo); 1990 Apr; 43(4):433-7. PubMed ID: 2141016
[No Abstract] [Full Text] [Related]
7. Synthesis and antifungal activities of novel 1,3-beta-D-glucan synthase inhibitors. Part 2.
Masubuchi K; Okada T; Kohchi M; Murata T; Tsukazaki M; Kondoh O; Yamazaki T; Satoh Y; Ono Y; Tsukaguchi T; Kobayashi K; Ono N; Inoue T; Horii I; Shimma N
Bioorg Med Chem Lett; 2001 May; 11(10):1273-6. PubMed ID: 11392535
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antifungal activities of novel 1,3-beta-D-glucan synthase inhibitors. Part 1.
Masubuchi K; Okada T; Kohchi M; Sakaitani M; Mizuguchi E; Shirai H; Aoki M; Watanabe T; Kondoh O; Yamazaki T; Satoh Y; Kobayashi K; Inoue T; Horii I; Shimma N
Bioorg Med Chem Lett; 2001 Feb; 11(3):395-8. PubMed ID: 11212119
[TBL] [Abstract][Full Text] [Related]
9. FR901469, a novel antifungal antibiotic from an unidentified fungus No.11243. II. In vitro and in vivo activities.
Fujie A; Iwamoto T; Muramatsu H; Okudaira T; Sato I; Furuta T; Tsurumi Y; Hori Y; Hino M; Hashimoto S; Okuhara M
J Antibiot (Tokyo); 2000 Sep; 53(9):920-7. PubMed ID: 11099225
[TBL] [Abstract][Full Text] [Related]
10. Echinocandin inhibition of 1,3-beta-D-glucan synthase from Candida albicans.
Sawistowska-Schröder ET; Kerridge D; Perry H
FEBS Lett; 1984 Jul; 173(1):134-8. PubMed ID: 6235127
[TBL] [Abstract][Full Text] [Related]
11. Total synthesis and antifungal evaluation of cyclic aminohexapeptides.
Klein LL; Li L; Chen HJ; Curty CB; DeGoey DA; Grampovnik DJ; Leone CL; Thomas SA; Yeung CM; Funk KW; Kishore V; Lundell EO; Wodka D; Meulbroek JA; Alder JD; Nilius AM; Lartey PA; Plattner JJ
Bioorg Med Chem; 2000 Jul; 8(7):1677-96. PubMed ID: 10976515
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP).
Balkovec JM; Black RM; Hammond ML; Heck JV; Zambias RA; Abruzzo G; Bartizal K; Kropp H; Trainor C; Schwartz RE
J Med Chem; 1992 Jan; 35(1):194-8. PubMed ID: 1732529
[No Abstract] [Full Text] [Related]
13. Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.
Schmatz DM; Abruzzo G; Powles MA; McFadden DC; Balkovec JM; Black RM; Nollstadt K; Bartizal K
J Antibiot (Tokyo); 1992 Dec; 45(12):1886-91. PubMed ID: 1490879
[TBL] [Abstract][Full Text] [Related]
14. The synthesis of water soluble prodrugs analogs of echinocandin B.
Rodriguez MJ; Vasudevan V; Jamison JA; Borromeo PS; Turner WW
Bioorg Med Chem Lett; 1999 Jul; 9(13):1863-8. PubMed ID: 10406656
[TBL] [Abstract][Full Text] [Related]
15. Photoaffinity analog of the semisynthetic echinocandin LY303366: identification of echinocandin targets in Candida albicans.
Radding JA; Heidler SA; Turner WW
Antimicrob Agents Chemother; 1998 May; 42(5):1187-94. PubMed ID: 9593148
[TBL] [Abstract][Full Text] [Related]
16. The synthesis and antifungal activity of N-alkylated analogs of echinocandin B.
Jamison JA; Zeckner DJ; Rodriguez MJ
J Antibiot (Tokyo); 1997 Jul; 50(7):562-6. PubMed ID: 9711248
[TBL] [Abstract][Full Text] [Related]
17. Cilofungin (LY121019) inhibits Candida albicans (1-3)-beta-D-glucan synthase activity.
Taft CS; Stark T; Selitrennikoff CP
Antimicrob Agents Chemother; 1988 Dec; 32(12):1901-3. PubMed ID: 2977537
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity of novel macrocyclic antifungals. modification of the tyrosine moiety of the lipopeptidolactone FR901469.
Barrett D; Tanaka A; Harada K; Watabe E; Maki K; Ikeda F
Bioorg Med Chem Lett; 2001 Jul; 11(14):1843-9. PubMed ID: 11459644
[TBL] [Abstract][Full Text] [Related]
19. L-671,329, a new antifungal agent. III. In vitro activity, toxicity and efficacy in comparison to aculeacin.
Fromtling RA; Abruzzo GK
J Antibiot (Tokyo); 1989 Feb; 42(2):174-8. PubMed ID: 2647704
[TBL] [Abstract][Full Text] [Related]
20. W-1 solubilization and kinetics of inhibition by cilofungin of Candida albicans (1,3)-beta-D-glucan synthase.
Tang J; Parr TR
Antimicrob Agents Chemother; 1991 Jan; 35(1):99-103. PubMed ID: 1826595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
